An improved total synthesis of spermatinamine, an inhibitor of isoprenylcysteine carboxy methyltransferase

  • Nisar Ullah*
  • , Shamsuddeen A. Haladu
  • , Basem A. Mosa
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

An improved total synthesis of spermatinamine, an inhibitor of the anticancer target, isoprenylcysteine carboxy methyltransferase (Icmt) was accomplished from the commercially available 3,4-dibromo-4-hydroxybenzaldehyde via a high yielding reaction sequence in an overall yield of 31%.

Original languageEnglish
Pages (from-to)212-214
Number of pages3
JournalTetrahedron Letters
Volume52
Issue number2
DOIs
StatePublished - 12 Jan 2011

Bibliographical note

Funding Information:
The research facilities and financial support by KFUPM Grant No: FT090014 are gratefully acknowledged.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anticancer drug
  • Azlactone formation
  • Icmt inhibitor
  • Spermatinamine

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'An improved total synthesis of spermatinamine, an inhibitor of isoprenylcysteine carboxy methyltransferase'. Together they form a unique fingerprint.

Cite this